期刊介绍
ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered.
ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition.
Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.
投稿要求
CITESCORE
CiteScore SJR SNIP CiteScore排名
7.50 1.230 0.997 学科 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology Q1 73 / 321 77%
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology (medical) Q1 43 / 275 84%
WOS期刊JCR分区
WOS分区等级:
2区| 按JIF指标学科分区 | 收录子集 | JIF分区 | JIF排名 | JIF百分位 |
| 学科:CHEMISTRY, MEDICINAL | ESCI | Q2 | 31/72 |
|
| 学科:PHARMACOLOGY & PHARMACY | ESCI | Q2 | 99/352 |
|
| 按JCI指标学科分区 | 收录子集 | JCI分区 | JCI排名 | JCI百分位 |
| 学科:CHEMISTRY, MEDICINAL | ESCI | Q1 | 13/72 |
|
| 学科:PHARMACOLOGY & PHARMACY | ESCI | Q1 | 52/353 |
|
期刊分区表预警名单
2025年03月发布的2025版:不在预警名单中
2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
中科院2025年3月升级版
点击查看中国科学院期刊分区趋势图| 大类学科 | 小类学科 | Top期刊 | 综述期刊 |
|---|
| 医学 1区3区1区 | CHEMISTRY, MEDICINAL 药物化学 | 3区2区3区 | PHARMACOLOGY & PHARMACY 药学 | 2区2区3区 |
| 否 | 否 |
中科院2023年12月旧的升级版
(没有被2023年的JCR升级版收录,仅供参考)